- Home
- AGRO vs CVAC Comparison
AGRO vs CVAC Comparison
Compare AGRO & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRO
- CVAC
- Stock Information
- Founded
- AGRO 2002
- CVAC 2000
- Country
- AGRO Luxembourg
- CVAC Germany
- Employees
- AGRO N/A
- CVAC N/A
- Industry
- AGRO Farming/Seeds/Milling
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- AGRO Consumer Staples
- CVAC Health Care
- Exchange
- AGRO Nasdaq
- CVAC Nasdaq
- Market Cap
- AGRO 990.2M
- CVAC 812.1M
- IPO Year
- AGRO 2011
- CVAC 2020
- Fundamental
- Price
- AGRO $9.65
- CVAC $4.10
- Analyst Decision
- AGRO Buy
- CVAC Hold
- Analyst Count
- AGRO 4
- CVAC 3
- Target Price
- AGRO $12.75
- CVAC $10.00
- AVG Volume (30 Days)
- AGRO 468.2K
- CVAC 1.2M
- Earning Date
- AGRO 03-13-2025
- CVAC 11-12-2024
- Dividend Yield
- AGRO 3.54%
- CVAC N/A
- EPS Growth
- AGRO 11.53
- CVAC N/A
- EPS
- AGRO 1.52
- CVAC N/A
- Revenue
- AGRO $1,408,633,000.00
- CVAC $70,565,734.00
- Revenue This Year
- AGRO $19.72
- CVAC $742.57
- Revenue Next Year
- AGRO $1.48
- CVAC N/A
- P/E Ratio
- AGRO $6.37
- CVAC N/A
- Revenue Growth
- AGRO 0.15
- CVAC 75.11
- 52 Week Low
- AGRO $8.72
- CVAC $2.22
- 52 Week High
- AGRO $12.08
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- AGRO 40.01
- CVAC 62.06
- Support Level
- AGRO $9.68
- CVAC $3.89
- Resistance Level
- AGRO $10.08
- CVAC $4.32
- Average True Range (ATR)
- AGRO 0.26
- CVAC 0.33
- MACD
- AGRO 0.08
- CVAC 0.03
- Stochastic Oscillator
- AGRO 50.57
- CVAC 54.27
About AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The company operates through three segments namely Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment consists of planting, harvesting, and sale of grains, oilseeds and fibers, rice, and production and sale of dairy products; the Sugar, Ethanol, and Energy segment consists of cultivating sugar cane which is processed in owned sugar mills, transformed into ethanol; and the Land Transformation segment comprises identification and acquisition of underdeveloped and undermanaged farmland.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.